Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
5.84
+0.27 (4.85%)
At close: Oct 27, 2026, 4:00 PM EDT
5.76
-0.08 (-1.37%)
After-hours: Oct 27, 2026, 4:15 PM EDT
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $39.61 million as of October 27, 2026. It is the 32,163rd most valuable company in the world and the 4,808th biggest in the United States. Its market cap has decreased by 69.76% in one year.
Market Cap
39.61M
Enterprise Value
57.35M
1-Year Change
-69.76%
Global Rank
Country Rank
#4,808 United States
Category
ChartMarket Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $39.61M, a decrease of -98.43%. That is a compound annual growth rate of -52.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 39.61M | -46.91% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Annovis Bio | 42.58M |
| Serina Therapeutics | 41.91M |
| Alterity Therapeutics | 41.09M |
| Grace Therapeutics | 40.60M |
| INmune Bio | 40.52M |
| GridAI Technologies | 39.69M |
| Aldeyra Therapeutics | 39.19M |
| Veru Inc. | 38.19M |